Burden of illness of transfusion-dependent beta thalassemia and sickle cell disease in Canada

Summary

Client: IQVIA Solutions Canada Inc.

Project ID: P2022-122 / 2023 0970 328 000

Research Question/Objectives: The client seeks to conduct a feasibility study.

Phase One

Identify sample sizes:

• of SCD and B-thalassemia cohorts.
• of SCD patients with recurrent VOCs sub-group, and B-thalassemia patients with transfusion-dependent thalassemia (TDT) subgroups.

Phase Two

Describe:

• baseline characteristics of cohorts and sub-groups
• acute and chronic complications of cohorts and sub-groups.
• treatment patterns of cohorts and sub-groups.

Results:

In progress